Laila Gharzai MD LLM
@LGharzai
Followers
269
Following
895
Media
2
Statuses
39
Pre-COVID world traveler, wannabe foodie, and cancer zapper @NorthwesternMed Radiation Oncology #radonc #hncsm #lcsm
Chicago, IL
Joined April 2018
RT @nu_ipham: Throat cancer survivor Paula Ruska and her doctor, @LGharzai , mark National #cancersurvivormonth by sharing their experience….
news.northwestern.edu
Survivor’s story inspired oncologist’s new study on gaps in post-cancer care
0
1
0
RT @RadiologyBiz: Unmet needs such as transport and finances forcing cancer patients to miss imaging appointments. @UCIMedSchool @Radiology….
radiologybusiness.com
Despite the prevalence of this concern, only 17% are screened for these health-related social challenges, experts write in JACR.
0
1
0
Our team demonstrates the first ever validation of COST Item 12 as a single item screening measure for financial toxicity—can be used as a brief, single item screener with excellent sensitivity for detecting patients at high risk of financial distress.
ascopubs.org
PURPOSEFinancial toxicity (FT) has been linked to higher symptom burden and poorer clinical outcomes for patients with cancer. Despite the availability of validated tools to measure FT, a simple...
0
0
1
RT @LurieCancer: Asking patients for guidance based on their lived experience is key, says Lurie Cancer Center's Laila Gharzai, MD, (@LGhar….
0
3
0
Excited to share our newest fin tox work—we ask cancer patients for guidance on how best to screen for financial toxicity. Patients tell us that they want screening to be early, often, and initiated by their providers. Important implications for policy.
ascopubs.org
PURPOSEFinancial toxicity is an important issue in cancer that affects quality of life and treatment adherence. Screening can identify patients at risk but consensus on appropriate timing or methods...
1
2
4
Short summary PRO measures offer the opportunity to frequently screen patients undergoing treatment without unduly burdening patients. We show that FACT GP5, assessing side effect bother, is a promising summary measure for head/neck cancer patients.
link.springer.com
Supportive Care in Cancer - Patients with head/neck squamous cell carcinomas (HNSCC) experience significant tumor- and treatment-related side effects. No efficient summary measure capturing the...
0
1
3
RT @rajatthawani: @OncLive Face-Off between @UChicagoHemOnc and @NorthwesternMed ! .Debated lung cancer, while discussing our rivalry! .Pur….
0
5
0
Poster #282 right now in the exhibit hall!.
Underway at #ASCO24, Laila Gharzai, MD, @LGharzai, is discussing the impact of biomarker testing in metastatic non-small cell lung cancer during the Quality Care / Health Service Research Session. @NorthwesternMed
0
1
5
RT @nadiasamaha_: Check out our paper on screening for financial toxicity in patients with cancer! #LeilaMady @LGharzai @hopkins_ent Preven….
jacr.org
Despite the pervasiveness and adverse impacts of financial toxicity (FT) in cancer care, there are no definitive measures for FT screening that have been widely integrated into clinical practice. The...
0
3
0
RT @JJCaudell: Surrogate endpoints for HPV+ HN cancer; an analysis of 5 NRG Oncology studies. LRPFS, DMFS, and PFS seem to fit the bill.….
0
7
0
Excited to share our work showing the first validation of surrogate endpoints in HPV+ oropharyngeal cancer! We show that LRPFS, DMFS, and PFS correlate with 5yr OS. Important for trial design in this evolving dx space @MierzwaMichelle @StatMatt9 @NRGonc .
1
3
23
RT @lcrf_org: LCRF Together Chicago is June 6 at The Ivy Room! Join our gathering & educational event with Drs. Nisha Mohindra, Jessica Don….
lungcancerresearchfoundation.org
Come join us at Quartino for an informative program, conversation, and a complimentary dinner. Our experts will discuss the latest research updates and important topics in lung cancer. Space is […]
0
3
0
RT @NEJMEvidence: Original Article: “Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer,” by @LGharzai et al. http….
0
2
0
RT @JournalCancer: Read our April 15 issue! 📗 . ✔️ Top advances in hepatobiliary cancer by @TimGreten & Coffman-D’….
0
4
0
RT @NU_WomenInMed: We are ✨ECSTATIC✨ to have you all join us TOMORROW for Northwestern's 5th annual Women in Medicine conference! . While o….
0
14
0
RT @JournalCancer: Financial impact of therapies should be measured. Patients who are informed of therapy implications—efficacy, side effec….
0
7
0
RT @LurieCancer: Don’t miss the @LurieCancer Multidisciplinary Head & Neck Symposium Dec. 2-3 @NorthwesternMed. The agenda features interna….
0
3
0
Had a fantastic time today chatting with my @CBSSM folks today on financial toxicity research I’ve done with @reshmajagsi, ways we can mitigate this devastating phenomenon…and experiencing my first zoom bomb!.
Join us tomorrow 2/9 at 2 pm ET for a CBSSM seminar with @LGharzai of @NUFeinbergMed!.Event details can be found here: @NorthwesternMed @umichmedicine @UMichRadOnc
0
2
6